Signal from the log
iPremom
15 M€ · Seed · Spain · Diagnostics
iPremom est une société valencienne de diagnostic moléculaire, essaimage de la Fondation Carlos Simón. Son test MaiRa lit l'ARN libre circulant dans le sang de la mère pour estimer, dès la neuvième semaine de grossesse, le risque de prééclampsie, une complication qui se déclare le plus souvent sans signe avant-coureur.
Article
Announced on , logged by the watch of 2 September 2026.
- Operation
- Funding round
- Announced amount
- 15 M€
- Stage
- Seed
- Country
- Spain
- Sector
- Diagnostics
What the log says
Editorial note, in French
Sujet traité. L'article donne les sources et la position de Bolus.
The investors
Led by Amadeus Capital Partners , with Asabys Partners , APEX Ventures
Provenance
Source pulse2,sifted
Logged on 2 September 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Article The operation led to an article, with its sources checked one by one.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.